Reduced levels of insulin-like growth factor-I (IGF-I) and/or insulin have been proposed as potential causes of these neurological disorders because IGF-I application reduces cognitive deficits (Ishii, 1995; Guo et al., 1999; Lupien et al., 2003). This evidence concerns the gene IGF1 and Cognitive impairment.